Redefining High Emergency Department Utilization for Sickle Cell Disease
This cohort study of 7 years of North Carolina Hospital Discharge Data described 4 new categories of ED utilization in SCD. These categories could be used to reframe how high ED use is determined.
Authors
- Camila Reyes
- Daniel Hatch (ORCID: https://orcid.org/0000-0003-0220-7059)
- John J. Strouse (ORCID: https://orcid.org/0000-0003-0341-1457)
- Paula Tanabe (ORCID: https://orcid.org/0000-0001-9933-6425)
- Wei Pan (ORCID: https://orcid.org/0000-0003-2410-9935)
- Lauren Siewny (ORCID: https://orcid.org/0000-0002-4941-5069)
- Mariam Kayle (ORCID: https://orcid.org/0000-0003-4393-4949)
- Matthew Young (ORCID: https://orcid.org/0000-0001-9366-0742)
- Audrey L. Blewer (ORCID: https://orcid.org/0000-0003-2830-5191)
Institutions
- Duke University (US)
- Waverly Hematology Oncology (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-06-02
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.13361
- Citations
- 5
- Primary Topic
- Hemoglobinopathies and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 8.13
Funders
- U.S. Department of Health and Human Services
- North Carolina Department of Health and Human Services
- CSL Behring
- Agios Pharmaceuticals
- Novo Nordisk
- National Institutes of Health
- Centers for Disease Control and Prevention
- Center for Scientific Review
- Cecil G. Sheps Center for Health Services Research, University of North Carolina, Chapel Hill
- School of Medicine, University of North Carolina at Chapel Hill